Related Experiment Video
Updated: Jul 20, 2026

Purification and Aggregation of the Amyloid Precursor Protein Intracellular Domain
Published on: August 28, 2012
A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I
Nan Wang1, Wengen Chen, Patrick Linsel-Nitschke
1Division of Molecular Medicine, Department of Medicine, Columbia University, New York, New York 10032, USA. nw30@columbia.edu
Abstract:
Cholesterol-loaded macrophage foam cells are a central component of atherosclerotic lesions. ABCA1, the defective molecule in Tangier disease, mediates the efflux of phospholipids and cholesterol from cells to apoA-I, reversing foam cell formation. In ABCA1, we identified a sequence rich in proline, glutamic acid, serine, and threonine (PEST sequence) that enhances the degradation of ABCA1 by calpain protease and thereby controls the cell surface concentration and cholesterol efflux activity of ABCA1. In an apparent positive feedback loop, apoA-I binds ABCA1, promotes lipid efflux, inhibits calpain degradation, and leads to increased levels of ABCA1. ApoA-I infusion also increases ABCA1 in vivo. These studies reveal a novel mode of regulation of ABCA1 by PEST sequence-mediated calpain proteolysis that appears to be reversed by apolipoprotein-mediated phospholipid efflux. Inhibition of ABCA1 degradation by calpain could represent a novel therapeutic approach to increasing macrophage cholesterol efflux and decreasing atherosclerosis.
Insights
Apolipoprotein A-I (apoA-I) binding to ABCA1 cholesterol transporter enhances lipid efflux and cell survival. This discovery offers a new therapeutic strategy for atherosclerosis by inhibiting ABCA1 degradation.
Area of Science:
- Biochemistry
- Cell Biology
- Molecular Medicine
Background:
- Cholesterol-loaded macrophage foam cells are key in atherosclerosis.
- ATP-binding cassette transporter A1 (ABCA1) facilitates cholesterol efflux to apolipoprotein A-I (apoA-I), reversing foam cell formation.
- ABCA1 dysfunction causes Tangier disease.
Purpose of the Study:
- To investigate the regulatory mechanisms of ABCA1 activity and stability.
- To explore the role of the PEST sequence in ABCA1 degradation.
- To identify potential therapeutic targets for atherosclerosis.
Main Methods:
- Identification of a PEST sequence within ABCA1.
- Assessing ABCA1 degradation by calpain protease.
- Investigating the effect of apoA-I binding on ABCA1 levels and activity.
- In vivo studies involving apoA-I infusion.
Main Results:
- A PEST sequence in ABCA1 enhances its degradation by calpain protease, controlling cell surface levels and cholesterol efflux.
- ApoA-I binding to ABCA1 promotes lipid efflux, inhibits calpain-mediated degradation, and increases ABCA1 levels.
- In vivo apoA-I infusion also elevates ABCA1 levels.
Conclusions:
- ABCA1 regulation involves PEST sequence-mediated calpain proteolysis, counteracted by apoA-I-mediated lipid efflux.
- Inhibiting calpain-dependent ABCA1 degradation presents a novel therapeutic strategy for increasing macrophage cholesterol efflux and reducing atherosclerosis.
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Anaphase Promoting Complex
Export of Misfolded Proteins out of the ER
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...

